Category Archives: Uncategorized

Refractory Wound Therapeutic NIH Grant

NIH grant to convert a potent IV
therapy for refractory wounds into
a topical formulation

Phoenicia has received a new small business grant from the National Institutes of Health for studies to convert an intravenous therapy which healed refractory, disabling leg ulcers in hemolytic anemias, sickle cell disease and β-thalassemia, into a topical preparation which can be used readily by patients world-wide. Continue reading

Phoenicia BioSciences Mission

The mission of Phoenicia Biosciences is to advance the development and translation of therapies for serious medical conditions for which current treatments are inadequate or lacking, particularly diseases affecting global populations.Ph-LOGO

Continue reading